Current status of hematopoietic stem cell transplant in chronic myeloid leukemia

被引：7

作者：

Gupta, Alok ^{[1
]}

Khattry, Navin ^{[1
]}

机构：

[1] Tata Mem Hosp, ACTREC, Dept Med Oncol, Bone Marrow Transplant Unit, Mumbai, Maharashtra, India

来源：

INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2014年 / 35卷 / 03期

关键词：

Chronic myeloid leukemia; hematopoietic stem cell transplant; posttransplant relapse;

D O I：

10.4103/0971-5851.142036

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Indications for hematopoietic stem cell transplant (HSCT) in chronic myeloid leukemia (CML) have changed over time. This change has largely been influenced by the advent of tyrosine kinase inhibitors, increased understanding of the mechanisms underlying disease phase progression as well as drug resistance, refinement of transplant techniques and exploitation of graft versus leukemia effect in this disease. Here, we have discussed the status of HSCT in CML in the present era with regards to the current indications, factors determining outcome and management strategies for posttransplant relapse.

引用

页码：207 / 210

页数：4

共 36 条

[1] Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. [J].

Bensinger, WI ;

Martin, PJ ;

Storer, B ;

Clift, R ;

Forman, SJ ;

Negrin, R ;

Kashyap, A ;

Flowers, MED ;

Lilleby, K ;

Chauncey, TR ;

Storb, R ;

Appelbaum, FR ;

Rowley, S ;

Heimfeld, S ;

Blume, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) :175-181

[2]

BIGGS JC, 1992, BLOOD, V80, P1352

[3] Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia [J].

Bornhaeuser, Martin ;

Thiede, Christian ;

Platzbecker, Uwe ;

Kiani, Alexander ;

Oelschlaegel, Uta ;

Babatz, Jana ;

Lehmann, Doris ;

Hoelig, Kristina ;

Radke, Joergen ;

Tuve, Sebastian ;

Wermke, Martin ;

Wehner, Rebekka ;

Jaehnisch, Hanka ;

Bachmann, Michael P. ;

Rieber, E. Peter ;

Schetelig, Johannes ;

Ehninger, Gerhard ;

Schmitz, Marc .

BLOOD, 2011, 117 (26) :7174-7184

[4]

CLIFT RA, 1993, BLOOD, V82, P1954

[5] MARROW TRANSPLANTATION FOR PATIENTS IN ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA [J].

CLIFT, RA ;

BUCKNER, CD ;

THOMAS, ED ;

BRYANT, E ;

ANASETTI, C ;

BENSINGER, WI ;

BOWDEN, R ;

DEEG, HJ ;

DONEY, KC ;

FISHER, LD ;

HANSEN, JA ;

MARTIN, P ;

MCDONALD, GB ;

SANDERS, JE ;

SCHOCH, G ;

SINGER, J ;

STORB, R ;

SULLIVAN, KM ;

WITHERSPOON, RP ;

APPELBAUM, FR .

BLOOD, 1994, 84 (12) :4368-4373

[6] A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies [J].

Couban, S ;

Simpson, DR ;

Barnett, MJ ;

Bredeson, C ;

Hubesch, L ;

Kang, HL ;

Shore, TB ;

Walker, IR ;

Browett, P ;

Messner, HA ;

Panzarella, T ;

Lipton, JH .

BLOOD, 2002, 100 (05) :1525-1531

[7] Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia [J].

Dazzi, F ;

Szydlo, RM ;

Craddock, C ;

Cross, NCP ;

Kaeda, J ;

Chase, A ;

Olavarria, E ;

van Rhee, F ;

Kanfer, E ;

Apperley, JF ;

Goldman, JM .

BLOOD, 2000, 95 (01) :67-71

[8] Extended follow-up of patients treated with imatinib mesylate (Gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation:: Durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease [J].

Deangelo, DJ ;

Hochberg, EP ;

Alyea, EP ;

Longtine, J ;

Lee, S ;

Galinsky, I ;

Parekkedon, B ;

Ritz, J ;

Antin, JH ;

Stone, RM ;

Soiffer, RJ .

CLINICAL CANCER RESEARCH, 2004, 10 (15) :5065-5071

[9] Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia [J].

Druker, Brian J. ;

Guilhot, Francois ;

O'Brien, Stephen G. ;

Gathmann, Insa ;

Kantarjian, Hagop ;

Gattermann, Norbert ;

Deininger, Michael W. N. ;

Silver, Richard T. ;

Goldman, John M. ;

Stone, Richard M. ;

Cervantes, Francisco ;

Hochhaus, Andreas ;

Powell, Bayard L. ;

Gabrilove, Janice L. ;

Rousselot, Philippe ;

Reiffers, Josy ;

Cornelissen, Jan J. ;

Hughes, Timothy ;

Agis, Hermine ;

Fischer, Thomas ;

Verhoef, Gregor ;

Shepherd, John ;

Saglio, Giuseppe ;

Gratwohl, Alois ;

Nielsen, Johan L. ;

Radich, Jerald P. ;

Simonsson, Bengt ;

Taylor, Kerry ;

Baccarani, Michele ;

So, Charlene ;

Letvak, Laurie ;

Larson, Richard A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2408-2417

[10] Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant [J].

Eapen, M ;

Giralt, SA ;

Horowitz, MM ;

Klein, JP ;

Wagner, JE ;

Zhang, MJ ;

Tallman, MS ;

Marks, DI ;

Camitta, BM ;

Champlin, RE ;

Ringdén, O ;

Bredeson, CN ;

Martino, R ;

Gale, RP ;

Cairo, MS ;

Litzow, MR ;

deLima, M .

BONE MARROW TRANSPLANTATION, 2004, 34 (08) :721-727

← 1 2 3 4 →